Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2015 Sep 14;21(34):9999-10007.
doi: 10.3748/wjg.v21.i34.9999.

Clinical comparison of antrum-preserving double tract reconstruction vs roux-en-Y reconstruction after gastrectomy for Siewert types II and III adenocarcinoma of the esophagogastric junction

Affiliations
Comparative Study

Clinical comparison of antrum-preserving double tract reconstruction vs roux-en-Y reconstruction after gastrectomy for Siewert types II and III adenocarcinoma of the esophagogastric junction

Jiang-Wei Xiao et al. World J Gastroenterol. .

Abstract

Aim: To explore a reasonable method of digestive tract reconstruction, namely, antrum-preserving double-tract reconstruction (ADTR), for patients with adenocarcinoma of the esophagogastric junction (AEG) and to assess its efficacy and safety in terms of long-term survival, complications, morbidity and mortality.

Methods: A total of 55 cases were retrospectively collected, including 18 cases undergoing ADTR and 37 cases of Roux-en-Y reconstruction (RY) for AEG (Siewert types II and III) at North Sichuan Medical College. The cases were divided into two groups. The clinicopathological characteristics, perioperative outcomes, postoperative complications, morbidity and overall survival (OS) were compared for the two different reconstruction methods.

Results: Basic characteristics including sex, age, body mass index (BMI), Siewert type, pT status, pN stage, and lymph node metastasis were similar in the two groups. No significant differences were found between the two groups in terms of perioperative outcomes (including the length of postoperative hospital stay, operating time, and intraoperative blood loss) and postoperative complications (consisting of anastomosis-related complications, wound infection, respiratory infection, pleural effusion, lymphorrhagia, and cholelithiasis). For the ADTR group, perioperative recovery indexes such as time to first flatus (P = 0.002) and time to resuming a liquid diet (P = 0.001) were faster than those for the RY group. Moreover, the incidence of reflux esophagitis was significantly decreased compared with the RY group (P = 0.048). The postoperative morbidity and mortality rates for overall postoperative complications and the rates of tumor recurrence and metastasis were not significantly different between the two groups. Survival curves plotted using the Kaplan-Meier method and compared by log-rank test demonstrated similar outcomes for the ADTR and RY groups. Multivariate analysis of significantly different factors that presented as covariates on Cox regression analysis to assess the survival and recurrence among AEG patients showed that age, gender, BMI, pleural effusion, time to resuming a liquid diet, lymphorrhagia and tumor-node-metastasis stage were important prognostic factors for OS of AEG patients, whereas the selection of surgical method between ADTR and RY was shown to be a similar prognostic factor for OS of AEG patients.

Conclusion: ADTR by jejunal interposition presents similar rates of tumor recurrence, metastasis and long-term survival compared with classical reconstruction with RY esophagojejunostomy; however, it offers considerably improved near-term quality of life, especially in terms of early recovery and decreased reflux esophagitis. Thus, ADTR is recommended as a worthwhile digestive tract reconstruction method for Siewert types II and III AEG.

Keywords: Adenocarcinoma of the esophagogastric junction; Antrum-preserving double-tract reconstruction; Overall survival; Roux-Y reconstruction; Total gastrectomy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Modified Siewert’s classification according to the distance of the tumor epicenter from the anatomical cardia. Reproduced from Mariette et al[2].
Figure 2
Figure 2
Antrum-preserving double-tract reconstruction. In our study, the jejunum was divided approximately 20 cm distal to the ligament of Treitz, an end-to-side esophagojejunal anastomosis (A) was performed, and the bottom of the proximal jejunum limb was anastomosed to the side of the Roux limb using a circular stapler at approximately 35 cm distal to the esophagojejunal anastomosis (C). Then, a side-to-side gastrojejunal anastomosis (B) was performed at 20 cm to the jejunojejunal anastomosis, and a pyloroplasty (D) was necessarily implemented.
Figure 3
Figure 3
The extent of systematic lymphadenectomy in the antrum-preserving double-tract reconstruction approach for adenocarcinoma of the esophagogastric junction. The details of the antrum-preserving double-tract reconstruction method are as follows: we divided the omentum majus along the transverse colon, then stripped the anterior lobe of the transverse mesocolon and isolated the pancreatic capsule at the inferior pancreatic edge and at the head of the pancreas. Then, we skeletonized the right gastroepiploic artery and vein but preserved their completeness with a No. 6 lymphadenectomy. Based on the Japanese gastric cancer treatment guidelines 2010 (ver. 3), the common hepatic artery, left and right gastric vessels, proximal splenic artery and left gastroepiploic vessels were all skeletonized and ligated, with the exception of the common hepatic artery. In addition, the lymph nodes that are marked in the left figure (such as Nos. 7, 8a, 9, 1, 3, and 11p) were dissected, whereas the resection of No. 16 was controversial.
Figure 4
Figure 4
Kaplan-Meier graph showing overall survival in patients grouped according to operative procedure. P = 0.716 between groups. RY: Roux-en-Y reconstruction; ADTR: Antrum-preserving double-tract reconstruction.

References

    1. Buas MF, Vaughan TL. Epidemiology and risk factors for gastroesophageal junction tumors: understanding the rising incidence of this disease. Semin Radiat Oncol. 2013;23:3–9. - PMC - PubMed
    1. Mariette C, Piessen G, Briez N, Gronnier C, Triboulet JP. Oesophagogastric junction adenocarcinoma: which therapeutic approach? Lancet Oncol. 2011;12:296–305. - PubMed
    1. Hasegawa S, Yoshikawa T. Adenocarcinoma of the esophagogastric junction: incidence, characteristics, and treatment strategies. Gastric Cancer. 2010;13:63–73. - PubMed
    1. Chung JW, Lee GH, Choi KS, Kim DH, Jung KW, Song HJ, Choi KD, Jung HY, Kim JH, Yook JH, et al. Unchanging trend of esophagogastric junction adenocarcinoma in Korea: experience at a single institution based on Siewert’s classification. Dis Esophagus. 2009;22:676–681. - PubMed
    1. Huang Q. Carcinoma of the gastroesophageal junction in Chinese patients. World J Gastroenterol. 2012;18:7134–7140. - PMC - PubMed

Publication types

MeSH terms